Drug Deal Disclosure Act

Hozzl · 2026-05-14T16:37:18Z

Explore the details of Senate Bill 4355 Drug Deal Disclosure Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

5/14/2026, 4:37 PM

Summary of Bill S 4355

A bill introduced in the 119th Congress, designated as S. 4355, aims to compel the Department of Health and Human Services to disclose documents, communications, and details concerning most favored nation pricing agreements and private drug pricing arrangements with manufacturers.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 4355

Bill S 4355 is currently in the status of Bill Introduced since April 21, 2026. Bill S 4355 was introduced during Congress 119 and was introduced to the Senate on April 21, 2026. Bill S 4355's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 21, 2026

Bipartisan Support of Bill S 4355

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 4355

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4355

A bill to require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.